Home/Filings/4/0001209191-05-034295
4//SEC Filing

MORGAN R ANDREW 4

Accession 0001209191-05-034295

CIK 0001009405other

Filed

Jun 30, 8:00 PM ET

Accepted

Jul 1, 8:22 AM ET

Size

16.2 KB

Accession

0001209191-05-034295

Insider Transaction Report

Form 4
Period: 2005-07-01
MORGAN R ANDREW
VP-Reg Affairs
Transactions
  • Disposition to Issuer

    BCII Stock Option Plan

    2005-07-01$29.60/sh20,000$592,0000 total
    Exercise: $3.40Exp: 2012-07-24BCII Common Stock (20,000 underlying)
  • Disposition to Issuer

    BCII Restricted Stock Units

    2005-07-01$33.00/sh10,000$330,0000 total
  • Disposition to Issuer

    BCII Stock Option Plan

    2005-07-01$11.88/sh5,000$59,4000 total
    Exercise: $21.12Exp: 2014-06-22BCII Common Stock (5,000 underlying)
  • Disposition to Issuer

    BCII Common stock

    2005-07-01$33.00/sh65,000$2,145,0000 total
Footnotes (3)
  • [F1]Disposed of pursuant to agreement and plan of merger between issuer and Genzyme Corporation and Macbeth Corporation in exchange for a cash payment of $33.00 per share of BCII Common Stock.
  • [F2]Disposed of pursuant to agreement and plan of merger between issuer and Genzyme Corporation and Macbeth Corporation in exchange for a cash payment of $33.00 per BCII Restricted Stock Unit.
  • [F3]Each BCII Stock Option became exercisable in full upon consummation of the merger and was cancelled in the merger and was cancelled in the merger in exchange for a cash payment per share subject to the option equal to the difference between the exercise price of the option and $33.00.

Issuer

BONE CARE INTERNATIONAL INC

CIK 0001009405

Entity typeother

Related Parties

1
  • filerCIK 0001202778

Filing Metadata

Form type
4
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 8:22 AM ET
Size
16.2 KB